Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2018

Aug 31, 2018

29777_dirs_2018-08-31_b5a5a50f-1fdc-48f3-b4c7-5658e66cd052.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-08-29

Reporting Person: LANE ANDREW H (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-08-29 Common shares without par value S 100 $67.121 Disposed 35576 Direct
2018-08-29 Common shares without par value S 8697 $67.111 Disposed 26879 Direct
2018-08-29 Common shares without par value S 100 $67.12 Disposed 26779 Direct
2018-08-29 Common shares without par value S 100 $67.1201 Disposed 26679 Direct
2018-08-29 Common shares without par value S 100 $67.121 Disposed 26583 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 1247 Indirect

Footnotes

F1: Includes shares acquired pursuant to a dividend reinvestment feature.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of August 29, 2018.